+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Integrin Alpha 4"

From
Integrin Alpha 4 - Pipeline Review, H1 2020 - Product Thumbnail Image

Integrin Alpha 4 - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 105 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Integrin Alpha 4 (ITGA4) is a protein found on the surface of cells that plays a role in cell adhesion and migration. In oncology, ITGA4 is a target for drugs that can be used to treat cancer. ITGA4 is involved in the process of metastasis, which is the spread of cancer cells from the primary tumor to other parts of the body. Drugs that target ITGA4 can help to prevent metastasis and slow the progression of cancer. ITGA4-targeting drugs are being developed for a variety of cancer types, including breast, lung, and colorectal cancer. These drugs are designed to block the activity of ITGA4, preventing cancer cells from migrating and metastasizing. Companies in the ITGA4 market include AstraZeneca, Merck, and Novartis. These companies are developing drugs that target ITGA4 in order to improve the treatment of cancer. Show Less Read more